Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas Marcopulos is active.

Publication


Featured researches published by Nicholas Marcopulos.


Tetrahedron Letters | 1995

Application of 5-lithiotetrazoles in organic synthesis

Yoshitaka Satoh; Nicholas Marcopulos

Abstract Lithiation of 1-benzyl and 1- p -methoxybenzyltetrazole at the 5-position with n -butyllithium followed by treatment with electrophiles gave functionalized 1-benzylic tetrazoles, which were converted into the 1-unsubstituted derivatives by debenzylation.


Tetrahedron Letters | 1999

ENANTIOSELECTIVE SYNTHESIS OF 4-SUBSTITUTED PHENYLALANINES BY CROSS-COUPLING REACTIONS

Fariborz Firooznia; Candido Gude; Kenneth Chan; Nicholas Marcopulos; Yoshitaka Satoh

The enantiomerically enriched BOC-protected (4-pinacolylborono)phenylalanine methyl ester (8) is produced via enzymatic resolution of the racemic material, or direct synthesis from the corresponding iodide (or triflate), and undergoes Suzuki-Miyaura coupling reactions with aromatic halides and triflates in the presence of catalytic amounts of PdCl2(dppf) to produce enantiomerically enriched 4-substituted phenylalanine derivatives.


Journal of Medicinal Chemistry | 2011

Discovery of Orally Active Carboxylic Acid Derivatives of 2-Phenyl-5-trifluoromethyloxazole-4-carboxamide as Potent Diacylglycerol Acyltransferase-1 Inhibitors for the Potential Treatment of Obesity and Diabetes

Yimin Qian; Stanley Wertheimer; Mushtaq Ahmad; Adrian Wai-Hing Cheung; Fariborz Firooznia; Matthew Michael Hamilton; Stuart Hayden; Shiming Li; Nicholas Marcopulos; Lee McDermott; Jenny Tan; Weiya Yun; Liang Guo; Anjula Pamidimukkala; Yingsi Chen; Kuo-Sen Huang; Gwendolyn Ramsey; Toni Whittard; Karin Conde-Knape; Rebecca Taub; Cristina M. Rondinone; Jefferson Wright Tilley; David Robert Bolin

Diacylglycerol acyltransferase-1 (DGAT-1) is the enzyme that catalyzes the final and committed step of triglyceride formation, namely, the acylation of diacylglycerol with acyl coenzyme A. DGAT-1 deficient mice demonstrate resistance to weight gain on high fat diet, improved insulin sensitivity, and reduced liver triglyceride content. Inhibition of DGAT-1 thus represents a potential novel approach for the treatment of obesity, dyslipidemia, and metabolic syndrome. In this communication, we report the identification of the lead structure 6 and our lead optimization efforts culminating in the discovery of potent, selective, and orally efficacious carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamides. In particular, compound 29 (DGAT-1 enzyme assay, IC(50) = 57 nM; CHO-K1 cell triglyceride formation assay, EC(50) = 0.5 μM) demonstrated dose dependent inhibition of weight gain in diet induced obese (DIO) rats (0.3, 1, and 3 mg/kg, p.o., qd) during a 21-day efficacy study. Furthermore, compound 29 demonstrated improved glucose tolerance determined by an oral glucose tolerance test (OGTT).


Tetrahedron Letters | 1998

Synthesis of tetrazole analogs of α-amino acids by alkylation of a Schiff base of α-aminomethyltetrazole

Yoshitaka Satoh; Stéphane De Lombaert; Nicholas Marcopulos; John Anthony Moliterni; Michael Moskal; Jenny Tan; Eli M. Wallace

Abstract A benzophenone imine of N-1 protected α-aminomethyltetrazoles was found to undergo alkylation with organic halides in good yields. Deprotection afforded tetrazole analogs of α-amino acids.


Journal of Medicinal Chemistry | 1998

Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.

Eli M. Wallace; John Anthony Moliterni; Michael Moskal; Alan D. Neubert; Nicholas Marcopulos; Lisa B. Stamford; Angelo J. Trapani; Paula Savage; Mary Chou; Arco Y. Jeng


Journal of Medicinal Chemistry | 2005

Perhydroquinolylbenzamides as Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1

Gary Mark Coppola; Paivi Jaana Kukkola; James L. Stanton; Alan D. Neubert; Nicholas Marcopulos; Natalie A. Bilci; Hua Wang; Hollis C. Tomaselli; Jenny Tan; Thomas Daniel Aicher; Douglas C. Knorr; Arco Y. Jeng; Beatriz N. Dardik; Ricardo E. Chatelain


Journal of Medicinal Chemistry | 1991

Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives

John A. Butera; Walter Spinelli; Viji Anantharaman; Nicholas Marcopulos; Roderick W. Parsons; Issam F. Moubarak; Catherine Cullinan; Jehan F. Bagli


Archive | 2007

Thiazolo-pyrimidine/pyridine urea derivatives

John A. Brinkman; Adrian Wai-Hing Cheung; Fariborz Firooznia; Kevin Richard Guertin; Nicholas Marcopulos; Lida Qi; Jagdish Kumar Racha; Ramakanth Sarabu; Jenny Tan; Jefferson Wright Tilley


Archive | 2012

Aminomethyl quinolone compounds

Joseph Anthony Bilotta; Adrian Wai-Hing Cheung; Fariborz Firooznia; Kevin Richard Guertin; Stuart Hayden; Nancy-Ellen Haynes; Christine M. Lukacs-Lesburg; Nicholas Marcopulos; Eric Mertz; Lida Qi; Yimin Qian; Sung-Sau So; Jenny Tan; Kshitij Chhabilbhai Thakkar


Archive | 2008

Compuestos derivados de tiazolo-pirimidina-urea, antiparasitos activos del receptor de adenosina a2b; composicion farmaceutica que comprende a dichos compuestos; y su uso del compuesto en el tratamiento y profilaxis de diabetes, retinopatia asma y diarrea.

Fariborz Firooznia; Kevin Richard Guertin; Lida Qi; John A. Brinkman; Adrian Wai-Hing Cheung; Nicholas Marcopulos; Jagdi

Collaboration


Dive into the Nicholas Marcopulos's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lida Qi

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge